Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

Li Sichen; Wang Rui; Yang Yue; Liu Xin; Cui Youbin; Tang Ze; Cai Hongfei

doi:10.3389/fphar.2023.1263726

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

Front Pharmacol. 2023 Sep 25:14:1263726. doi: 10.3389/fphar.2023.1263726. eCollection 2023.

Authors

Li Sichen^#¹, Wang Rui^#^{1

2}, Yang Yue¹, Liu Xin¹, Cui Youbin¹, Tang Ze¹, Cai Hongfei¹

Affiliations

¹ Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
² School of Public Health, Jilin University, Changchun, China.

^# Contributed equally.

Abstract

Objective: The objective of this study is to determine the drug resistance status of pulmonary tuberculosis patients in Jilin Province. Methods: A retrospective survey was conducted on 395 sputum culture TB-positive patients admitted to the tuberculosis hospital in Jilin Province in 2019. Sputum samples were cultured in acidic Roche medium. Drug sensitivity testing was conducted using the proportional method. Sensitivity was reported if the percentage of drug resistance was less than 1%, and resistance was reported if the percentage was ≥1%. Statistical analysis was performed using SPSS 22.0. Results: 395 tuberculosis patients with positive sputum tuberculosis culture were included in the study, with 102 being initially treated and 293 being retreated. The study population consisted of 283 males and 112 females. Sex, age, nationality, occupation, marital status, diabetes comorbidity, initial treatment, normal health status, BCG vaccine vaccination, smoking, and alcohol consumption were considered as factors that may affect the rate of multidrug resistance. And only the history of treatment (initial treatment) was associated with multidrug resistance (p = 0.032). This indicates that retreatment is the most significant risk factor for the occurrence of multidrug resistance in tuberculosis. The multidrug resistance rate in retreated patients is 3.764 times higher than that in initially treated patients. Conclusion: The prevalence of multidrug-resistant is higher in retreated patients compared to initially treated patients in the study population. Multidrug resistance is only associated with the treatment history (initial retreatment) and not with other factors.

Keywords: drug resistant; initially treated; multidrug-resistant; pulmonary tuberculosis; retreated.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. National Nature Science Foundation of China (82002429). Science and Technology Department of Jilin Province (20130604050TC and 20210204123YY).